JP7418587B2 - 経口投与用の新しい遅延放出組成物 - Google Patents

経口投与用の新しい遅延放出組成物 Download PDF

Info

Publication number
JP7418587B2
JP7418587B2 JP2022540547A JP2022540547A JP7418587B2 JP 7418587 B2 JP7418587 B2 JP 7418587B2 JP 2022540547 A JP2022540547 A JP 2022540547A JP 2022540547 A JP2022540547 A JP 2022540547A JP 7418587 B2 JP7418587 B2 JP 7418587B2
Authority
JP
Japan
Prior art keywords
formulation
acid
respiratory
use according
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022540547A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023504292A (ja
Inventor
キャンバー，オラ
ヨハンソン，クリスティーナ
Original Assignee
ヴィコール ファルマ アーベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヴィコール ファルマ アーベー filed Critical ヴィコール ファルマ アーベー
Publication of JP2023504292A publication Critical patent/JP2023504292A/ja
Priority to JP2023169472A priority Critical patent/JP7663647B2/ja
Application granted granted Critical
Publication of JP7418587B2 publication Critical patent/JP7418587B2/ja
Priority to JP2025062545A priority patent/JP2025106410A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2022540547A 2020-04-24 2021-04-23 経口投与用の新しい遅延放出組成物 Active JP7418587B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023169472A JP7663647B2 (ja) 2020-04-24 2023-09-29 経口投与用の新しい遅延放出組成物
JP2025062545A JP2025106410A (ja) 2020-04-24 2025-04-04 経口投与用の新しい遅延放出組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2006074.5 2020-04-24
GBGB2006074.5A GB202006074D0 (en) 2020-04-24 2020-04-24 New composition
PCT/GB2021/050993 WO2021214487A1 (en) 2020-04-24 2021-04-23 New delayed release composition for peroral administration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023169472A Division JP7663647B2 (ja) 2020-04-24 2023-09-29 経口投与用の新しい遅延放出組成物

Publications (2)

Publication Number Publication Date
JP2023504292A JP2023504292A (ja) 2023-02-02
JP7418587B2 true JP7418587B2 (ja) 2024-01-19

Family

ID=71080159

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2022540547A Active JP7418587B2 (ja) 2020-04-24 2021-04-23 経口投与用の新しい遅延放出組成物
JP2023169472A Active JP7663647B2 (ja) 2020-04-24 2023-09-29 経口投与用の新しい遅延放出組成物
JP2025062545A Pending JP2025106410A (ja) 2020-04-24 2025-04-04 経口投与用の新しい遅延放出組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023169472A Active JP7663647B2 (ja) 2020-04-24 2023-09-29 経口投与用の新しい遅延放出組成物
JP2025062545A Pending JP2025106410A (ja) 2020-04-24 2025-04-04 経口投与用の新しい遅延放出組成物

Country Status (26)

Country Link
US (3) US11654115B2 (enExample)
EP (2) EP4218737A1 (enExample)
JP (3) JP7418587B2 (enExample)
KR (1) KR20230005239A (enExample)
CN (1) CN115811971A (enExample)
AU (1) AU2021258542A1 (enExample)
BR (1) BR112022021520A2 (enExample)
CA (1) CA3180850A1 (enExample)
DK (1) DK4138789T3 (enExample)
ES (1) ES2955915T3 (enExample)
FI (1) FI4138789T3 (enExample)
GB (1) GB202006074D0 (enExample)
HR (1) HRP20231012T1 (enExample)
HU (1) HUE062897T2 (enExample)
IL (1) IL297374A (enExample)
LT (1) LT4138789T (enExample)
MA (1) MA59397B1 (enExample)
MD (1) MD4138789T2 (enExample)
MX (1) MX2022013069A (enExample)
PL (1) PL4138789T3 (enExample)
PT (1) PT4138789T (enExample)
RS (1) RS64568B1 (enExample)
SI (1) SI4138789T1 (enExample)
SM (1) SMT202300289T1 (enExample)
WO (1) WO2021214487A1 (enExample)
ZA (1) ZA202211461B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202004094D0 (en) * 2020-03-20 2020-05-06 Vicore Pharma Ab New compounds and uses
GB202006074D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
JP2025506498A (ja) 2022-02-10 2025-03-11 ヴィコール ファルマ アーベー 特発性肺線維症の処置のためのブロキシブチドの使用
GB202201723D0 (en) * 2022-02-10 2022-03-30 Vicore Pharma Ab New use

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003325642A (ja) 2002-05-09 2003-11-18 Sansho Pharmaceutical Co Ltd 腸溶性皮膜付き硬質空カプセルと、腸溶性皮膜付き硬質空カプセルの製造方法と、腸溶性皮膜付き硬質カプセル剤
JP2008502699A (ja) 2004-06-14 2008-01-31 セプラコール・インコーポレイテッド 肺疾患治療方法、及びそのための組成物
WO2017022248A1 (ja) 2015-08-04 2017-02-09 富士カプセル株式会社 腸溶性カプセル
JP2017515880A (ja) 2014-05-19 2017-06-15 ティロッツ・ファルマ・アクチエンゲゼルシャフトＴｉｌｌｏｔｔｓ Ｐｈａｒｍａ Ａｇ 放出調節コーティングカプセル
JP2017515879A (ja) 2014-05-19 2017-06-15 ティロッツ・ファルマ・アクチエンゲゼルシャフトＴｉｌｌｏｔｔｓ Ｐｈａｒｍａ Ａｇ 放出調節コーティングカプセル
JP2018507244A (ja) 2015-03-02 2018-03-15 ビーコレ ファルマ アクティエボラーグ 肺線維症の治療のためのアンギオテンシンｉｉ受容体作動薬
WO2019183513A1 (en) 2018-03-22 2019-09-26 University Of Iowa Research Foundation Compositions and methods for the treatment and prevention of muscular dystrophy
JP2019182746A (ja) 2018-04-02 2019-10-24 三生医薬株式会社 ハードカプセル用コーティング剤及びそれを用いたハードカプセル剤の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59139317A (ja) * 1983-01-31 1984-08-10 Teisan Seiyaku Kk 持続性のニフエジピン製剤
SE9800550D0 (sv) 1998-02-24 1998-02-24 A & Science Invest Ab A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
DK1395566T3 (da) 2001-05-31 2008-01-07 Vicore Pharma Ab Tricycliske forbindelser, der er nyttige som angiotensin Il-agonister
PL1673107T3 (pl) * 2003-10-10 2008-06-30 Abbott Laboratories Gmbh Kompozycja farmaceutyczna zawierająca selektywnego agonistę receptora imidazoliny I1 i bloker receptora angiotensyny II
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
WO2017221012A1 (en) 2016-06-21 2017-12-28 Vicore Pharma Ab Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity
GB201710906D0 (en) 2017-07-06 2017-08-23 Vicore Pharma Ab Compounds and methods for treating peripheral neuropathy
GB201818164D0 (en) 2018-11-07 2018-12-19 Vicore Pharma Ab New composition
GB202006074D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202006079D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202201723D0 (en) 2022-02-10 2022-03-30 Vicore Pharma Ab New use

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003325642A (ja) 2002-05-09 2003-11-18 Sansho Pharmaceutical Co Ltd 腸溶性皮膜付き硬質空カプセルと、腸溶性皮膜付き硬質空カプセルの製造方法と、腸溶性皮膜付き硬質カプセル剤
JP2008502699A (ja) 2004-06-14 2008-01-31 セプラコール・インコーポレイテッド 肺疾患治療方法、及びそのための組成物
JP2017515880A (ja) 2014-05-19 2017-06-15 ティロッツ・ファルマ・アクチエンゲゼルシャフトＴｉｌｌｏｔｔｓ Ｐｈａｒｍａ Ａｇ 放出調節コーティングカプセル
JP2017515879A (ja) 2014-05-19 2017-06-15 ティロッツ・ファルマ・アクチエンゲゼルシャフトＴｉｌｌｏｔｔｓ Ｐｈａｒｍａ Ａｇ 放出調節コーティングカプセル
JP2018507244A (ja) 2015-03-02 2018-03-15 ビーコレ ファルマ アクティエボラーグ 肺線維症の治療のためのアンギオテンシンｉｉ受容体作動薬
WO2017022248A1 (ja) 2015-08-04 2017-02-09 富士カプセル株式会社 腸溶性カプセル
WO2019183513A1 (en) 2018-03-22 2019-09-26 University Of Iowa Research Foundation Compositions and methods for the treatment and prevention of muscular dystrophy
JP2019182746A (ja) 2018-04-02 2019-10-24 三生医薬株式会社 ハードカプセル用コーティング剤及びそれを用いたハードカプセル剤の製造方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
AAPS PharmSciTech，2008年，Vol. 9, No. 1，pp. 116-121

Also Published As

Publication number Publication date
US11654115B2 (en) 2023-05-23
DK4138789T3 (da) 2023-09-11
PT4138789T (pt) 2023-08-29
JP2024001089A (ja) 2024-01-09
BR112022021520A2 (pt) 2023-01-24
ZA202211461B (en) 2025-02-26
MD4138789T2 (ro) 2023-11-30
EP4138789B1 (en) 2023-06-07
IL297374A (en) 2022-12-01
KR20230005239A (ko) 2023-01-09
PL4138789T3 (pl) 2023-12-11
JP2025106410A (ja) 2025-07-15
HRP20231012T1 (hr) 2023-12-08
SI4138789T1 (sl) 2023-11-30
US20230364022A1 (en) 2023-11-16
ES2955915T3 (es) 2023-12-11
US12121614B2 (en) 2024-10-22
GB202006074D0 (en) 2020-06-10
MX2022013069A (es) 2022-11-30
SMT202300289T1 (it) 2023-11-13
US20250235408A1 (en) 2025-07-24
JP2023504292A (ja) 2023-02-02
JP7663647B2 (ja) 2025-04-16
HUE062897T2 (hu) 2023-12-28
CN115811971A (zh) 2023-03-17
EP4138789A1 (en) 2023-03-01
WO2021214487A1 (en) 2021-10-28
AU2021258542A1 (en) 2022-12-01
CA3180850A1 (en) 2021-10-28
LT4138789T (lt) 2023-09-25
MA59397B1 (fr) 2023-11-30
EP4218737A1 (en) 2023-08-02
FI4138789T3 (fi) 2023-08-28
RS64568B1 (sr) 2023-10-31
US20220202729A1 (en) 2022-06-30

Similar Documents

Publication Publication Date Title
JP7418587B2 (ja) 経口投与用の新しい遅延放出組成物
JP7387903B2 (ja) 経口投与用の新しい乾燥粉末組成物
US20250177355A1 (en) Treatment of idiopathic pulmonary fibrosis
US11819494B2 (en) Treatment of idiopathic pulmonary fibrosis
JP2023522411A (ja) 経口投与用の新しいカプセル組成物
HK40090175A (en) New delayed release composition for peroral administration
HK40088609B (en) New delayed release composition for peroral administration
HK40088609A (en) New delayed release composition for peroral administration
EA049971B1 (ru) Новая композиция с отсроченным высвобождением для перорального введения

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220817

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220817

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20220817

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230214

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230405

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230530

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230929

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230929

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20231124

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231219

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240109

R150 Certificate of patent or registration of utility model

Ref document number: 7418587

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150